Nosopharm

French tech company | Builders Republic

About

Biotech company developing first-in-class antibiotics and anti-infective compounds — using a proprietary natural product discovery platform based on Xenorhabdus and Photorhabdus bacterial genera to address antimicrobial resistance.

Key facts

Status
Morte
Sectors
Healthcare & Life Sciences
Latest stage
Extension
Founded
2009
City
LYON
Region
Occitanie
Tracked rounds
1
Amount raised
1.6 M€ raised since 2020

Funding rounds

  • Extension — 2020

Investors

Notes

Liquidation judiciaire prononcée le 15/05/2024 (TC Lyon, Selarl MJ Synergie). Le domaine nosopharm.com a été récupéré par un tiers et sert du spam de casino : ne pas le remettre.